Medical Giant Abbott Labs Announces a Push Into Biowearables at CES

The devices will track levels of glucose, lactate and ketones in users' bodies

Today’s consumer places a huge priority on personal health. Join Adweek for Prescription for Growth: Health and Wellness Marketing on April 19 in NYC to learn how to thrive in this business sector. Sign up now.

Medical tech company Abbott Labs announced a new line of wearable devices designed to track certain measures of user health in a keynote address at the Consumer Electronics Show this week in Las Vegas.

The healthcare giant’s new Lingo devices will monitor levels of substances like glucose, lactate, ketones and eventually alcohol in the body through a sensor worn on the user’s arm. Abbott was the first healthcare company to host a keynote session at CES, a sign of the trade show’s increasing push into the consumer-health tech space in recent years.

“It’s

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in